Financial Connections Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-139
Closed -$6K 234
2025
Q2
$6K Buy
+139
New +$6.82K ﹤0.01% 205
2024
Q1
Sell
-2,000
Closed -$102K 173
2023
Q4
$102K Buy
+2,000
New +$105K 0.07% 75
2023
Q3
Sell
-2,830
Closed -$180K 134
2023
Q2
$180K Buy
+2,830
New +$190K 0.12% 59
2022
Q3
Sell
-898
Closed -$69K 231
2022
Q2
$69K Sell
898
-80
-8% -$6.09K 0.06% 88
2022
Q1
$71K Sell
978
-373
-28% -$25K 0.07% 83
2021
Q4
$84K Buy
+1,351
New +$79.3K 0.08% 81

Other funds holding BMY

Financial Connections Group's BMY Position: Q3 2025 in Review

Financial Connections Group sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 139 shares — an estimated $6K sold.

Financial Connections Group first reported a position in BMY in Q4 2021 and held it in 6 quarters. The position peaked at $180K in Q2 2023. 2,274 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Financial Connections Group reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Financial Connections Group sold 139 Bristol-Myers Squibb shares in Q3 2025, an estimated $6K.
  • Financial Connections Group first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 6 quarters.
  • Financial Connections Group's Bristol-Myers Squibb position peaked at $180K in Q2 2023.
  • 2,274 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Financial Connections Group's 13F filing for Q3 2025, filed 10 Oct 2025.